Common press release of the Helmholtz Centre for Infection Research and the Saarland University
A draft of the new HIPS building, which will unite drug researchers under one roof.
Architekten BDA RDS PARTNER
Infection research meets pharmacy: At the HIPS approximately 150 scientists are committed to the search for new drugs. The ground-breaking ceremony on Wednesday, 21 August, marks the beginning of the construction of a new research building. Media representatives are invited to attend the greetings at 10:00 and the breaking ground at approximately 11:00. There will be the possibility for press photos and background discussion.
Prof. Johanna Wanka, the German Federal Minister of Education and Research, and Annegret Kramp-Karrenbauer, the State Prime Minister of Saarland, will attend the ground-breaking ceremony. Also Prof. Jürgen Mlynek, President of the Helmholtz Association, is expected to be present.
Many antibiotics, once celebrated as miracle drugs against infectious diseases, have long lost their potency to the unrelenting rise in antibiotic resistance. As a result, new drugs are desperately needed.
In order to close a gap in drug research, the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, and the Saarland University founded the HIPS in 2009. Almost exactly four years later, the symbolic ground-breaking ceremony on 21 August will be the starting signal for construction of a new HIPS building to begin. On about 4,500 square metres of effective area, three departments and an additional three junior research groups will find new space on the campus of the Saarland University. "So far, our labs are distributed all over the campus," says Prof. Rolf Müller, Managing Director of the HIPS. "In 2015, the new building will be completed, and all staff can then be accommodated under one roof. It will even offer space for new research groups."
The cost, which totals 25 million euros, is funded for a substantial part by the German State of Saarland as well as the European Regional Development Fund. The European Union contribution is aimed at promoting competitiveness in this region. The HIPS’ own share of the cost is 10 %.
“Infection research is the HZI’s focus, whereas traditionally the Saarland University has been strong in pharmaceutical research,” says Prof. Dirk Heinz, the HZI’s scientific director. “The combination with HIPS areas of competence is unprecedented in Germany.” The HIPS is Germany’s first publicly funded non-university-affiliated research institute exclusively dedicated to pharmaceutical research. Scientists are screening natural substances for their therapeutic potential. "Bacteria, fungi and plants produce many highly active metabolites, including antibacterials," explains Müller. When researchers discover an interesting substance, they optimize it for pharmaceutical application using different methods. In addition, HIPS scientists are conducting research into how drugs ultimately arrive at their intended target in the body. To enable drugs to cross biological barriers, they develop drug transporters.
“Saarland University is among the best universities in Germany when it comes to pharmaceutical research. With the new building, novel interesting perspectives will open up for junior researchers,” says Saarland University’s President Prof. Volker Linneweber.
Media representatives are invited to attend the ceremony on the construction site in Stuhlsatzenhausweg. Parking is possible in the car park at Stuhlsatzenhausweg – Entrance Uni Ost. For additional questions, please contact the HZI Public Relations Department at (+49) 531-6181-1401 or by email at: firstname.lastname@example.org.The Helmholtz Centre for Infection Research (HZI)
http://www.helmholtz-hzi.deThe Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)
Dr. Birgit Manno | Helmholtz-Zentrum
Turning carbon dioxide into liquid fuel
06.08.2020 | DOE/Argonne National Laboratory
Tellurium makes the difference
06.08.2020 | Friedrich-Schiller-Universität Jena
Scientists at the Fraunhofer Institute for Laser Technology ILT have come up with a striking new addition to contact stamping technologies in the ERDF research project ScanCut. In collaboration with industry partners from North Rhine-Westphalia, the Aachen-based team of researchers developed a hybrid manufacturing process for the laser cutting of thin-walled metal strips. This new process makes it possible to fabricate even the tiniest details of contact parts in an eco-friendly, high-precision and efficient manner.
Plug connectors are tiny and, at first glance, unremarkable – yet modern vehicles would be unable to function without them. Several thousand plug connectors...
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.
Osteoporosis is the most common age-related bone disease which affects hundreds of millions of individuals worldwide. It is estimated that one in three women...
Traditional single-cell sequencing methods help to reveal insights about cellular differences and functions - but they do this with static snapshots only...
“Core-shell” clusters pave the way for new efficient nanomaterials that make catalysts, magnetic and laser sensors or measuring devices for detecting electromagnetic radiation more efficient.
Whether in innovative high-tech materials, more powerful computer chips, pharmaceuticals or in the field of renewable energies, nanoparticles – smallest...
An international research team with Prof. Cornelia Denz from the Institute of Applied Physics at the University of Münster develop for the first time light fields using caustics that do not change during propagation. With the new method, the physicists cleverly exploit light structures that can be seen in rainbows or when light is transmitted through drinking glasses.
Modern applications as high resolution microsopy or micro- or nanoscale material processing require customized laser beams that do not change during...
23.07.2020 | Event News
21.07.2020 | Event News
07.07.2020 | Event News
06.08.2020 | Earth Sciences
06.08.2020 | Power and Electrical Engineering
06.08.2020 | Life Sciences